Carl Zeiss Meditec AG (ETR:AFX) Receives Average Recommendation of “Hold” from Analysts

Carl Zeiss Meditec AG (ETR:AFX) has received a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is €78.25 ($90.99).

Several research analysts have recently commented on the company. Hauck & Aufhaeuser set a €92.50 ($107.56) target price on Carl Zeiss Meditec and gave the stock a “buy” rating in a report on Monday, April 15th. HSBC set a €84.00 ($97.67) target price on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Tuesday, May 7th. Independent Research set a €76.50 ($88.95) target price on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Monday, April 15th. Berenberg Bank set a €80.00 ($93.02) target price on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Wednesday, May 22nd. Finally, Deutsche Bank set a €80.00 ($93.02) target price on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Friday, May 17th.

ETR AFX opened at €87.55 ($101.80) on Friday. The company has a debt-to-equity ratio of 4.55, a quick ratio of 3.09 and a current ratio of 4.11. The company has a market cap of $7.98 billion and a price-to-earnings ratio of 61.05. Carl Zeiss Meditec has a 1-year low of €57.60 ($66.98) and a 1-year high of €90.60 ($105.35).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Article: What is the NASDAQ Stock Market?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.